Elsevier

Atherosclerosis

Volume 183, Issue 1, November 2005, Pages 1-16
Atherosclerosis

Review
Rho and vascular disease

https://doi.org/10.1016/j.atherosclerosis.2005.04.023Get rights and content

Abstract

The Rho family GTPases are regulatory molecules that link surface receptors to organisation of the actin cytoskeleton and play major roles in fundamental cellular processes. In the vasculature Rho signalling pathways are intimately involved in the regulation of endothelial barrier function, inflammation and transendothelial leukocyte migration, platelet activation, thrombosis and oxidative stress, as well as smooth muscle contraction, migration, proliferation and differentiation, and are thus implicated in many of the changes associated with atherogenesis. Indeed, it is believed that many of the beneficial, non-lipid lowering effects of statins occur as a result of their ability to inhibit Rho protein activation. Conversely, the Rho proteins can have beneficial effects on the vasculature, including the promotion of endothelial repair and the maintenance of SMC differentiation. Further identification of the mechanisms by which these proteins and their effectors act in the vasculature should lead to therapies that specifically target only the adverse effects of Rho signalling.

Introduction

The Rho family GTPases (of which Rho, Rac, Cdc42 are best characterised) are regulatory molecules that link surface receptors to organisation of the actin cytoskeleton [1] and regulate fundamental cellular processes [2], [3], [4], [5], [6]. In the vasculature, RhoA regulates smooth muscle contraction [7] and expression of smooth muscle differentiation marker genes [8] and has been implicated for a role in smooth muscle cell (SMC) phenotypic modulation [9], [10]. Both Rac and Rho are implicated in endothelial barrier function, endothelial migration and wound repair [11]. These observations, along with demonstrations that some of the beneficial effects of the statins may be due to their ability to inhibit Rho family GTPases [12] have led our laboratory and others to propose that members of the Rho family are critical to vascular function.

This review will examine the known roles of Rho family proteins in the vasculature, with particular emphasis on the role of RhoA and its impact on atherogenesis.

Section snippets

The Rho family of small GTPases

The gene for Rho (from ‘Ras homologous’) was first described in 1985 [13] as a cloning artefact from a gene family derived from the mollusc Aplysia gene library, and has since been found in almost all cells [14]. The Rho GTPases form a sub-group within the Ras superfamily of small GTP-binding proteins. To date, 22 Rho genes encoding more than 25 proteins have been identified in humans, and these have been divided into six groups [15] of which RhoA, Rac and Cdc42 are considered the ‘classical’

Inhibitors of Rho activity

Many of the functions of Rho family proteins have been elucidated using a range of inhibitors, the most prominent of these being the statins. Statins inhibit HMG CoA reductase, the rate-limiting enzyme of the mevalonate pathway through which cells synthesise cholesterol from acetate moieties (Fig. 2). However, by inhibiting mevalonate synthesis, statins also prevent the synthesis of isoprenoid intermediates, farnesylpyrophosphate and geranylgeranylpyrophosphate [70], lipid attachments important

Rho proteins in the vasculature

Rho family GTPases have been implicated for roles in almost every aspect of vascular biology, influencing the biology of endothelial cells, smooth muscle cells, leukocytes and platelets, and regulating such diverse processes as vasoreactivity and hypertension, inflammation and wound healing, neointimal formation and thrombosis. This review will focus on the role of Rho family proteins in the pathogenesis of atherosclerosis.

Concluding remarks

Rho family signalling pathways are intimately involved with regulation of the vasculature, influencing almost every aspect of vascular homeostasis and mediating the changes associated with atherogenesis. Rho proteins have been demonstrated to play a role in regulating endothelial barrier function, inflammation and transendothelial leukocyte migration, platelet activation, thrombosis and oxidative stress as well as smooth muscle contraction, migration, proliferation, differentiation and

Acknowledgements

This research was funded by the Heart Foundation of Australia and the Ronald Geoffrey Arnott Foundation.

References (236)

  • J.V. Small et al.

    Functional design in the actin cytoskeleton

    Curr Opin Cell Biol

    (1999)
  • P.M. Ghosh et al.

    Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells

    Biochim Biophys Acta

    (1997)
  • C.S. Hill et al.

    The Rho family GTPases RhoA, Rac1, and Cdc42Hs regulate transcriptional activation by SRF

    Cell

    (1995)
  • K.A. DeMali et al.

    Integrin signaling to the actin cytoskeleton

    Curr Opin Cell Biol

    (2003)
  • V.M. Braga

    Cell–cell adhesion and signalling

    Curr Opin Cell Biol

    (2002)
  • A.J. Ridley

    Rho-related proteins: actin cytoskeleton and cell cycle

    Curr Opin Gen Cell Dev

    (1995)
  • S.H. Zigmond

    Signal transduction and actin filament organization

    Curr Opin Cell Biol

    (1996)
  • M. Amano et al.

    Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase)

    J Biol Chem

    (1996)
  • K. Burridge et al.

    Rho and Rac take center stage

    Cell

    (2004)
  • F. Li et al.

    The mouse Formin mDia1 is a potent actin nucleation factor regulated by autoinhibition

    Curr Biol

    (2003)
  • K. Kimura et al.

    Regulation of the association of adducin with actin filaments by Rho-associated kinase (Rho-kinase) and myosin phosphatase

    J Biol Chem

    (1998)
  • L.D. Chong et al.

    The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells

    Cell

    (1994)
  • S. Bagrodia et al.

    Identification of a mouse p21Cdc42/Rac activated kinase

    J Biol Chem

    (1995)
  • M. Symons

    Rho family GTPases: the cytoskeleton and beyond

    Trends Biochem Sci

    (1996)
  • A. Minden et al.

    Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs

    Cell

    (1995)
  • S. Bagrodia et al.

    Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation

    J Biol Chem

    (1995)
  • S. Montaner et al.

    Multiple signalling pathways lead to the activation of the nuclear factor kappaB by the Rho family of GTPases

    J Biol Chem

    (1998)
  • A.S. Alberts et al.

    Activation of SRF-regulated chromosomal templates by Rho-family GTPases requires a signal that also induces H4 hyperacetylation

    Cell

    (1998)
  • S. Osada et al.

    A domain containing the Cdc42/Rac interactive binding (CRIB) region of p65PAK inhibits transcriptional activation and cell transformation mediated by the Ras-Rac pathway

    FEBS Lett

    (1997)
  • K. Aktories et al.

    In vitro ADP-ribosylation of Rho by bacterial ADP-ribosyltransferases

    Methods Enzymol

    (1995)
  • K. Aktories

    Rho proteins: targets for bacterial toxins

    Trends Microbiol

    (1997)
  • M. Lerm et al.

    Bacterial protein toxins targeting rho GTPases

    FEMS Microbiol Lett

    (2000)
  • E. Sahai et al.

    Transformation mediated by RhoA requires activity of ROCK kinases

    Curr Biol

    (1999)
  • S. Narumiya et al.

    Use and properties of ROCK-specific inhibitor Y-27632

    Methods Enzymol

    (2000)
  • M. Amano et al.

    The COOH terminus of Rho-kinase negatively regulates rho-kinase activity

    J Biol Chem

    (1999)
  • S. Blankenberg et al.

    Adhesion molecules and atherosclerosis

    Atherosclerosis

    (2003)
  • A. Hall

    Rho GTPases and the actin cytoskeleton

    Science

    (1998)
  • A. Hall et al.

    Cellular responses regulated by Rho-related small GTP-binding proteins

    J Biochem

    (1993)
  • M.F. Olson et al.

    An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1

    Science

    (1995)
  • H. Takano et al.

    The Rho family G proteins play a critical role in muscle differentiation

    Mol Cell Biol

    (1998)
  • N.F. Worth et al.

    Rho expression and activation in vascular smooth muscle cells

    Cell Motil Cytoskeleton

    (2004)
  • N.F. Worth et al.

    A role for rho in smooth muscle phenotypic regulation

    Ann N Y Acad Sci

    (2001)
  • M. Aepfelbacher et al.

    Bacterial toxins block endothelial wound repair. Evidence that Rho GTPases control cytoskeletal rearrangements in migrating endothelial cells

    Arterioscler Thromb Vasc Biol

    (1997)
  • U. Laufs et al.

    Targeting Rho in cardiovascular disease

    Circ Res

    (2000)
  • K. Wennerberg et al.

    Rho-family GTPases: it's not only Rac and Rho (and I like it)

    J Cell Sci

    (2004)
  • A. Hall

    The Rho subfamily of small GTPases

  • A.J. Ridley

    Microinjection of Rho and Rac into quiescent Swiss 3T3 cells

    Methods Enzymol

    (1995)
  • C.D. Nobes et al.

    Rho Rac and Cdc42 GTPases: regulators of actin structures, cell adhesion and motility

    Biochem Soc Trans

    (1995)
  • D.I. Johnson

    Cdc42: an essential Rho-type GTPase controlling eukaryotic cell polarity

    Microbiol Mol Biol Rev

    (1999)
  • I.R. Nabi

    The polarization of the motile cell

    J Cell Sci

    (1999)
  • Cited by (0)

    View full text